AVR (ASX) Global future

Originally posted by tomboy ↑

Heres some sample AGM questions:-
- to Catlow & Rowley - why did AF sell his shares at the peak SP of 17c last year? And why did Emichrome sell their shares at 11c? You know them both well, tell us all why?
- so you boys made $20M to $30M in FMG, so why has this SP collapsed 2 years in a a row being the worst BIOASX performer since 2013?
- Where are the Canada & Asia CC sale results and why cant the TGA approve CC here?
- Why are the expenses still exceeding the income?
- to all those holders who paid $32M cash for CR at 7c and have lost $Millions in value, what message do you have for them as to why they should continue to lose $Millions investing in AHZ?
- If CC is so good why are the expenses still lower than the costs
- Pr Frazer stated there was massive partnering interest on the clinical results that was 3 years ago, where is all that interest now at Phase 2
- what are the Phase 2 results and why did Frazer say they were similar to the clinical & animal testing results in his Youtube video in June posted on HC? Did he pre-release these results & do you agree with Pr Frazer's results he stated in that video?
- Since March when the first 2 cohorts where injected with monthly vaccines, with now over 8 monthly injections since, shold not the results of these injections been known to you and AV labs by June already and why are you witholding these results released already to the market by Pr Frazer in June?
- what is the status of the court proceedings re Regen?
- To Rodne, in your Morgans Video in Sept 2014 you promised us LTHs major news over the next 6 months, that was over 14 months ago, did you really mean that major news was a large cheap CR that would collapse the SP to 6c from 15c and make us all lose 66% of our share value and if not then what other news were you referring to then?
- why have you or Pr Frazers shutdown research into skin cancer and HIV & HepC as mentioned by Proactive Investors in 2013?
- In Feb 2014 you announced a joint CSIRO research into Adapt/CC expnaded uses, why has that secret report not been released to the public for now over 19 months ago and what if any are the results of this research or has CSIRO deliberately kept them secret from you and from the market?
- Why are these pipelines of numerous undisclosed CC ADAPT & AVaccine products kept secret from the market and why not disclose those products and research?
- In 2014 you announced HPV Phase 1 trials, why have these trials taken over 2 years and havent even started yet?
- What do you hope to achieve in a 1-10 consolidation?
- Why did Pr Frazer inject his Mice with 500 times the lethal dose of the HSV2 antivirus? Was that a defacto human sample trial that was successful.
- Are you opening a clean room no 4 at the malaga factory hence all those renovation works there for the last 6 months?
- why didnt AF take shares in the 7c CR in Feb? Why isnt he on the Board
- Why are you hiding the HSV2 phase 2 results since June?

Would I get kicked out of the AGM for these questions, should i ask them? The WASPS/oldies will have a heart attack.

Expand

Finally a post from you that is not over the top hype, well done! Ask these Q's, most of us would be very appreciative.

No.	Vol.	Price($)
1	500	$11.05

No.

Vol.

Price($)

500

$11.05

Price($)	Vol.	No.
$11.90	99	1

Price($)

Vol.

No.

$11.90

No.	Vol.	Price($)
1	400	12.000
1	335	11.900
1	1000	11.750
1	1000	11.500
1	1000	11.300

No.

Vol.

Price($)

400

12.000

335

11.900

1000

11.750

1000

11.500

1000

11.300

Price($)	Vol.	No.
11.980	120	2
12.000	2489	1
12.050	9	1
12.100	1220	1
12.400	500	1

Price($)

Vol.

No.

11.980

120

12.000

2489

12.050

12.100

1220

12.400

500

(20min delay)
Last $11.90		Change 1.050(9.68%)		Mkt cap ! $251.5M

Open	High	Low	Value	Volume
$11.00	$11.90	$10.85	$504.4K	45.27K

Global future, page-49

Brookside taking a run at US listing – the latest to tap liquidity beyond the ASX

Catalyst ups 3Y gold production guidance by 100,000oz on back of 1Moz resource

Manawa acquisition set to boost Contact's renewable energy credentials

AuMega drilling program extends gold mineralisation at Canadian play

Swoop picks up 16.9% stake in Vonex after buyout rejected to challenge MaxoTel's $34M offer

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Global future, page-49

Top Stories

Brookside taking a run at US listing – the latest to tap liquidity beyond the ASX

Catalyst ups 3Y gold production guidance by 100,000oz on back of 1Moz resource

Manawa acquisition set to boost Contact's renewable energy credentials

AuMega drilling program extends gold mineralisation at Canadian play

Swoop picks up 16.9% stake in Vonex after buyout rejected to challenge MaxoTel's $34M offer

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News